Bide Pharmatech Co (SHSE:688073) Institutional Ownership: 16.22% (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688073 Bide Pharmatech Co Ltd SHSE:688073
88 GF Score
Price ¥62.56
GF Value ¥68.25
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Bide Pharmatech Co Institutional Ownership?

Bide Pharmatech Co SHSE:688073 -3.75% 88 Institutional Ownership is 16.22% as of Aug. 26, 2026. GuruFocus rates SHSE:688073 with a GF Score™ of 88/100 and a GF Value™ of ¥68.25 (Fairly Valued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bide Pharmatech Co's institutional ownership is 16.22%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bide Pharmatech Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bide Pharmatech Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Bide Pharmatech Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Bide Pharmatech Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bide Pharmatech Co Institutional Ownership Chart

Bide Pharmatech Co Historical Data

The historical data trend for Bide Pharmatech Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 15.44 15.45 16.23 16.22 16.22 16.22 16.22 16.22 16.22 16.22
SHSE:688073
88GF Score
Bide Pharmatech Co Ltd SHSE:688073
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bide Pharmatech Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 16.22% mean?
Bide Pharmatech Co (SHSE:688073) has a Institutional Ownership of 16.22% as of Aug. 26, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bide Pharmatech Co and its competitors.
Is Bide Pharmatech Co's Institutional Ownership too high?
Bide Pharmatech Co's current Institutional Ownership is 16.22%. Overall, Bide Pharmatech Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bide Pharmatech Co's Institutional Ownership compare to ZTS?
Bide Pharmatech Co's Institutional Ownership of 16.22% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bide Pharmatech Co and its competitors. Bide Pharmatech Co's current Institutional Ownership is 16.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bide Pharmatech Co stock overvalued right now?
Based on GuruFocus' analysis, Bide Pharmatech Co (SHSE:688073) is currently considered Fairly Valued. The stock's GF Value™ is ¥68.25, compared to a current price of ¥62.56 — trading 8.3% below its estimated fair value. The current Institutional Ownership is 16.22%. Bide Pharmatech Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Bide Pharmatech Co (SHSE:688073), the current Institutional Ownership is 16.22% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bide Pharmatech Co (SHSE:688073) Overvalued in 2026?

Based on GuruFocus' analysis, Bide Pharmatech Co stock appears to be undervalued. The current stock price of ¥62.56 is trading 8.3% below its estimated GF Value™ of ¥68.25. GuruFocus considers Bide Pharmatech Co to be Fairly Valued.

Key valuation signals for SHSE:688073:

  • Institutional Ownership: 16.22%
  • GF Value™: ¥68.25 vs. price of ¥62.56 (8.3% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688073 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bide Pharmatech Co Business Description

Address No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433
Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.
88GF Score

Get the complete analysis for SHSE:688073

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥62.56
Price
¥68.25
GF Value